AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20951370 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (30 mg intravenous)
Number of subjects: 32
Study 20951370 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD + MDD
Number of subjects: 32
Study 20951370 — intervention group
Group type: COMPARATOR
Intervention: PTSD - MDD
Number of subjects: 32
Study 20951370 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 32
Study 17430533 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of an introductory class and consecutive classes using a case discussion method.
Number of subjects: 0
Study 17430533 — intervention group
Group type: EXPERIMENTAL
Intervention: NANDA, NIC, and NOC nursing diagnoses, interventions, and outcomes implementation.
Number of subjects: 0
Study 15822086 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet commercials
Number of subjects: 193
Study 15822086 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet commercials (early)
Number of subjects: 193
Study 15822086 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet commercials (midway)
Number of subjects: 193
Study 15822086 — intervention group
Group type: COMPARATOR
Intervention: Neutral commercials
Number of subjects: 193
Study 12410536 — intervention group
Group type: EXPERIMENTAL
Intervention: surgical arm (n = 97)
Number of subjects: 183
Study 12410536 — intervention group
Group type: EXPERIMENTAL
Intervention: induction chemotherapy arm (n = 86)
Number of subjects: 183
Study 12410536 — intervention group
Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 183
Study 12410536 — intervention group
Group type: EXPERIMENTAL
Intervention: all patients (regardless of treatment group)
Number of subjects: 183
Study 7617555 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg x 3)
Number of subjects: 10
Study 7617555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2501544 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy for premenopausal patients
Number of subjects: 0
Study 2501544 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy for postmenopausal patients
Number of subjects: 0
Study 2501544 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy for receptor-positive patients
Number of subjects: 0
Study 2501544 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy for receptor-negative patients
Number of subjects: 0
Study 921254 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 376
Study 921254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 376
Study 921254 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 376
Study 921254 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 376
Study 31377709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-only training
Number of subjects: 750
Study 31377709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-motor training
Number of subjects: 750
Study 31377709 — intervention group
Group type: COMPARATOR
Intervention: Control group (minimal-intervention)
Number of subjects: 750
Study 28079572 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE
Number of subjects: 22
Study 27750131 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (4-week program of closed-chain resistive activities and abdominal exercises)
Number of subjects: 72
Study 27750131 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 72
Study 23262931 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy after downregulation (estradiol less than 50 pg/mL) by GnRH antagonist and agonist (arm II)
Number of subjects: 100
Study 23262931 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy after downregulation with GnRH agonist (arm IV)
Number of subjects: 100
Study 23262931 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (arm I)
Number of subjects: 100
Study 23262931 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (arm III)
Number of subjects: 100
Study 21878782 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone depression care management + treatment as usual (TAU)
Number of subjects: 38
Study 21878782 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 38
Study 19842222 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal liquid food (NLF)
Number of subjects: 80
Study 19842222 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie diet (HCD)
Number of subjects: 80
Study 19842222 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal liquid food (NLF) 2 hours before surgery
Number of subjects: 80
Study 19842222 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie diet (HCD) 2 hours before surgery
Number of subjects: 80
Study 19842222 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal liquid food (NLF) 3 hours before surgery
Number of subjects: 80
Study 19842222 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie diet (HCD) 5 hours before surgery
Number of subjects: 80
Study 16895612 — intervention group
Group type: EXPERIMENTAL
Intervention: low-Dye taping
Number of subjects: 92
Study 16895612 — intervention group
Group type: COMPARATOR
Intervention: sham ultrasound
Number of subjects: 92
Study 14564526 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-week programme of aerobic conditioning progressing to 75% of initial VO(2max)
Number of subjects: 742
Study 14564526 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-week programme of aerobic conditioning
Number of subjects: 742
Study 11387608 — intervention group
Group type: EXPERIMENTAL
Intervention: 4F power injection (Acist)
Number of subjects: 96
Study 11387608 — intervention group
Group type: COMPARATOR
Intervention: 4F manual technique
Number of subjects: 96
Study 9612618 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant multimodal treatment including pre- and postoperative chemoradiation, intraoperative radiotherapy (IORT), adjuvant chemotherapy, and regional infusion therapy.
Number of subjects: 0
Study 9612618 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing prospective randomized studies (ESPAC-1 and an EORTC study).
Number of subjects: 0
Study 8070499 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup (7.5 mg/kg)
Number of subjects: 154
Study 8070499 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen syrup (10 mg/kg)
Number of subjects: 154
Study 8070499 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ibuprofen and acetaminophen
Number of subjects: 154
Study 8070499 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup
Number of subjects: 154
Study 2732400 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental clinical model
Number of subjects: 173
Study 30659710 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of WML in type 1 diabetes patients
Number of subjects: 50
Study 30659710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (baseline)
Number of subjects: 50
Study 30659710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (peak hyperemia)
Number of subjects: 50
Study 30659710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (venous occlusion)
Number of subjects: 50
Study 30659710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower skin capillary perfusion in type 1 diabetes patients (capillary recruitment)
Number of subjects: 50
Study 28257277 — intervention group
Group type: EXPERIMENTAL
Intervention: In-school saccadic training (King-Devick Reading Acceleration Program Software), 18 sessions of 20 minutes over 5 weeks
Number of subjects: 327
Study 28257277 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 327
Study 26349877 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA for AVF
Number of subjects: 600
Study 26349877 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA for AVG
Number of subjects: 600
Study 26349877 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 600
Study 24640441 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal restorative system (Adper Single Bond 2 system and Filtek Z350)
Number of subjects: 132
Study 24640441 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin‐modified glass‐ionomer cement (Vitremer)
Number of subjects: 132
Study 24640441 — intervention group
Group type: EXPERIMENTAL
Intervention: Low shrink restorative system (Filtek P90)
Number of subjects: 132
Study 21816996 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic splinting (60 minutes, three times per day)
Number of subjects: 50
Study 21816996 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonsteroidal anti-inflammatory drugs, orthotics, and home exercise program without dynamic splinting)
Number of subjects: 50
Study 19015851 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-endoscopic anterior cervical discectomy (FACD)
Number of subjects: 103
Study 19015851 — intervention group
Group type: COMPARATOR
Intervention: Conventional anterior cervical decompression and fusion (ACDF)
Number of subjects: 103
Study 16390354 — intervention group
Group type: EXPERIMENTAL
Intervention: mequitazine 10 mg q.a.m.
Number of subjects: 16
Study 16390354 — intervention group
Group type: EXPERIMENTAL
Intervention: dexchlorpheniramine Repetab 6 mg b.i.d.
Number of subjects: 16
Study 16390354 — intervention group
Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg q.a.m.
Number of subjects: 16
Study 16390354 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 14504025 — intervention group
Group type: EXPERIMENTAL
Intervention: TREAT (Treatment Research Experiences and Attitudes Task) - a 50-item patient-administered measure of attitudes
Number of subjects: 152
Study 14504025 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients attending 80% or more clinical sessions
Number of subjects: 152
Study 10917410 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 0.5 mg once daily at night, increased to a maximum of 2 mg/day
Number of subjects: 16
Study 10917410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9300510 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy
Number of subjects: 71
Study 9300510 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological factors
Number of subjects: 71
Study 9300510 — intervention group
Group type: EXPERIMENTAL
Intervention: Beliefs about pain and evaluation of seriousness of condition
Number of subjects: 71
Study 7832031 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers participated in the educational intervention program workshops
Number of subjects: 0
Study 7832031 — intervention group
Group type: COMPARATOR
Intervention: Teachers did not participate in the educational intervention program workshops
Number of subjects: 0
Study 2451549 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional doses (1 mg/kg/day) of corticotherapy
Number of subjects: 383
Study 2451549 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses (0.25 mg/kg/day) of corticotherapy
Number of subjects: 383
Study 29729189 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 48
Study 29729189 — intervention group
Group type: COMPARATOR
Intervention: Low-Fat Diet (LF)
Number of subjects: 48
Study 28585260 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimel Antibacterial Manuka Eye Gel (98% Leptospermum species honey) plus conventional therapy, n = 37
Number of subjects: 114
Study 28585260 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimel Manuka plus Lubricant Eye Drops (16% Leptospermum species honey) plus conventional therapy, n = 37
Number of subjects: 114
Study 28585260 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy, n = 40
Number of subjects: 114
Study 26282937 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative hysteroscopy
Number of subjects: 572
Study 26282937 — intervention group
Group type: COMPARATOR
Intervention: Vacuum aspiration
Number of subjects: 572
Study 24496202 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐170H
Number of subjects: 0
Study 24496202 — intervention group
Group type: EXPERIMENTAL
Intervention: FLX‐18GW
Number of subjects: 0
Study 21062998 — intervention group
Group type: EXPERIMENTAL
Intervention: NEVO sirolimus-eluting coronary stent (NEVO SES)
Number of subjects: 394
Study 21062998 — intervention group
Group type: COMPARATOR
Intervention: TAXUS Liberté paclitaxel-eluting coronary stent (TAXUS Liberté PES)
Number of subjects: 394
Study 18165285 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 52
Study 18165285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 17174201 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 746
Study 17174201 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 746
Study 17174201 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombosis-related events
Number of subjects: 746
Study 12938052 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha2b (low dose) 3 million IU, twice a week for 2 years
Number of subjects: 57
Study 12938052 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha2b (high dose) 10 million IU, twice a week for 2 years
Number of subjects: 57
Study 12938052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 10629263 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue-engineered skin graft
Number of subjects: 31
Study 10629263 — intervention group
Group type: COMPARATOR
Intervention: Moist dressing changes
Number of subjects: 31
Study 9183072 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical retention brackets (Transcend)
Number of subjects: 49
Study 9183072 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical retention brackets (Transcend 2000)
Number of subjects: 49
Study 9183072 — intervention group
Group type: COMPARATOR
Intervention: Concise bonding agent
Number of subjects: 49
Study 9183072 — intervention group
Group type: COMPARATOR
Intervention: Transbond bonding agent
Number of subjects: 49
Study 1279784 — intervention group
Group type: EXPERIMENTAL
Intervention: sorbitol (2%)-mannitol (1%)
Number of subjects: 40
Study 1279784 — intervention group
Group type: COMPARATOR
Intervention: 1.5% glycine
Number of subjects: 40
Study 3306639 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 91
Study 3306639 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 91
Study 3306639 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 91
Study 29929157 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional bias modification (ABM)
Number of subjects: 54
Study 29929157 — intervention group
Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 54
Study 27628128 — intervention group
Group type: COMPARATOR
Intervention: Specific exercise training
Number of subjects: 36
Study 27628128 — intervention group
Group type: COMPARATOR
Intervention: Turning-based treadmill training
Number of subjects: 36
Study 24043557 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Engagement Process (CEP) used by the Children's Healthy Living (CHL) Program
Number of subjects: 900
Study 24043557 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Engagement Process (CEP)
Number of subjects: 900
Study 23595928 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyad practice group (n=24)
Number of subjects: 49
Study 23595928 — intervention group
Group type: COMPARATOR
Intervention: Single practice group (n=25)
Number of subjects: 49
Study 20364899 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional bias reduction
Number of subjects: 48
Study 20364899 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 48
Study 18596863 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of electronic medical records (EMRs) for performance measurement and improvement
Number of subjects: 0
Study 16875153 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg twice daily for 4 days
Number of subjects: 27
Study 16875153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 12828751 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine HCl 60 mg twice daily
Number of subjects: 400
Study 12828751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 10817857 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanotic congenital heart disease patients
Number of subjects: 22
Study 10817857 — intervention group
Group type: COMPARATOR
Intervention: Noncyanotic controls
Number of subjects: 22
Study 9017562 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-based telephone counseling (3 post-treatment calls)
Number of subjects: 288
Study 1625002 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention group (soft-tissue examination, advice to quit ST, self-help materials, short video, encouragement to set a quit date)
Number of subjects: 518
Study 1625002 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 518
Study 6134549 — intervention group
Group type: EXPERIMENTAL
Intervention: Proquazone
Number of subjects: 33
Study 6134549 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 33
Study 6134549 — intervention group
Group type: COMPARATOR
Intervention: Opiate analgesics
Number of subjects: 33
Study 6134549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 30753443 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for TPC risk using multivariable logistic regression.
Number of subjects: 440
Study 30753443 — intervention group
Group type: COMPARATOR
Intervention: Validation cohort of the prediction model.
Number of subjects: 440
Study 29742656 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine paracervical block
Number of subjects: 93
Study 27596284 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g/day of pecan nuts
Number of subjects: 0
Study 27596284 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml/day of olive oil
Number of subjects: 0
Study 27596284 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study 25730928 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP) combined with gaseous carbon dioxide baths and infrared laser therapy
Number of subjects: 40
Study 23110412 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 130/0.4
Number of subjects: 300
Study 23110412 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution
Number of subjects: 300
Study 20303789 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation >1000 microg
Number of subjects: 1846
Study 20303789 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation <1000 microg
Number of subjects: 1846
Study 17584547 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapies
Number of subjects: 3000
Study 17584547 — intervention group
Group type: EXPERIMENTAL
Intervention: Various definitions of bleeding
Number of subjects: 3000
Study 17584547 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized bleeding definitions
Number of subjects: 3000
Study 15813818 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab (750 mg, two doses, 1 week apart)
Number of subjects: 40
Study 12014211 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis (AP) with orally absorbable antibiotics: 250 mg ciprofloxacin twice a day, 150 mg roxithromycin twice a day, 50 mg fluconazole once a day
Number of subjects: 95
Study 12014211 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antimicrobial prophylaxis)
Number of subjects: 95
Study 12014211 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis (AP)
Number of subjects: 95
Study 10468294 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon alpha-2b (IFN-alpha-2b) intravenous: 20 MIU m(−2), 5 days a week for 4 weeks; subcutaneous: 10 MIU m(−2), 3 times a week for 11 months
Number of subjects: 36
Study 10468294 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon alpha-2b (IFN-alpha-2b)
Number of subjects: 36
Study 8725042 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous flow bladder irrigation
Number of subjects: 120
Study 8725042 — intervention group
Group type: COMPARATOR
Intervention: Suprapubic flow irrigation (without suction pump)
Number of subjects: 120
Study 8725042 — intervention group
Group type: COMPARATOR
Intervention: Without continuous flow irrigation
Number of subjects: 120
Study 2112640 — intervention group
Group type: COMPARATOR
Intervention: Control Formula (CF)
Number of subjects: 23
Study 2112640 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Formula (SF)
Number of subjects: 23
Study 538418 — intervention group
Group type: EXPERIMENTAL
Intervention: Guaiacolic ester of acetylsalicylic acid (ASA-G)
Number of subjects: 9
Study 538418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 29742522 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Intelligence (EI) training over a 6-month period
Number of subjects: 120
Study 29742522 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-training)
Number of subjects: 120
Study 30225786 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise with a behavioural approach (NSEB)
Number of subjects: 216
Study 30225786 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 216
Study 30225786 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE) and Neck-specific exercise with a behavioural approach (NSEB)
Number of subjects: 216
Study 30225786 — intervention group
Group type: COMPARATOR
Intervention: Physical activity prescription (PPA)
Number of subjects: 216
Study 28486634 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised patient education programme
Number of subjects: 248
Study 28486634 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 248